Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2406060 | 0.87 | DKK1 (0.42) | FFAR4CNR1 | |
| SCHEMBL2405627 | 0.87 | CNR1 (0.38) | FFAR4CNR1 | |
| SCHEMBL2411198 | 0.87 | PIM1 (0.36) | FFAR4 | |
| SCHEMBL2406718 | 0.87 | KMO (0.38) | FFAR4CNR1 | |
| SCHEMBL2408111 | 0.86 | PRKD1 (0.37) | FFAR4CNR1 | |
| SCHEMBL2406555 | 0.86 | KDM4E (0.39) | FFAR4 | |
| SCHEMBL2404007 | 0.85 | CPT2 (0.35) | FFAR4 | |
| SCHEMBL2405635 | 0.85 | PIM2 (0.36) | FFAR4CNR1 | |
| SCHEMBL2407113 | 0.85 | SMN1; SMN2 (0.44) | FFAR4CNR1 | |
| SCHEMBL2411477 | 0.85 | CNR1 (0.40) | CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8912218-B2 | Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof | SANOFI (FR) | 2014-12-16 | — | — | US | disclosed |
| US-20110212963-A1 | ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212963-A1 | ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | MET, ALK, REL | FFAR4 677/4885CNR1 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.